BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18773906)

  • 1. Lesion-targeted thrombopoietin potentiates vasculogenesis by enhancing motility and enlivenment of transplanted endothelial progenitor cells via activation of Akt/mTOR/p70S6kinase signaling pathway.
    Eguchi M; Masuda H; Kwon S; Shirakura K; Shizuno T; Ito R; Kobori M; Asahara T
    J Mol Cell Cardiol; 2008 Nov; 45(5):661-9. PubMed ID: 18773906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes.
    Chanprasert S; Geddis AE; Barroga C; Fox NE; Kaushansky K
    Cell Signal; 2006 Aug; 18(8):1212-8. PubMed ID: 16380230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
    Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
    Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle.
    Hur J; Yoon CH; Lee CS; Kim TY; Oh IY; Park KW; Kim JH; Lee HS; Kang HJ; Chae IH; Oh BH; Park YB; Kim HS
    Stem Cells; 2007 Jul; 25(7):1769-78. PubMed ID: 17412896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian target of rapamycin is required for thrombopoietin-induced proliferation of megakaryocyte progenitors.
    Drayer AL; Olthof SG; Vellenga E
    Stem Cells; 2006 Jan; 24(1):105-14. PubMed ID: 16123382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
    Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In human endothelial cells amino acids inhibit insulin-induced Akt and ERK1/2 phosphorylation by an mTOR-dependent mechanism.
    Pellegatta F; Catapano AL; Luzi L; Terruzzi I
    J Cardiovasc Pharmacol; 2006 May; 47(5):643-9. PubMed ID: 16775502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young environment reverses the declined activity of aged rat-derived endothelial progenitor cells: involvement of the phosphatidylinositol 3-kinase/Akt signaling pathway.
    Zhu G; Song M; Wang H; Zhao G; Yu Z; Yin Y; Zhao X; Huang L
    Ann Vasc Surg; 2009; 23(4):519-34. PubMed ID: 19540437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells.
    Romanelli RG; Petrai I; Robino G; Efsen E; Novo E; Bonacchi A; Pagliai G; Grossi A; Parola M; Navari N; Delogu W; Vizzutti F; Rombouts K; Gentilini P; Laffi G; Marra F
    Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G120-8. PubMed ID: 16150872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of endothelial progenitor cells transferred by vascular endothelial growth factor gene for vascular regeneration of ischemic flaps.
    Yi C; Xia W; Zheng Y; Zhang L; Shu M; Liang J; Han Y; Guo S
    J Surg Res; 2006 Sep; 135(1):100-6. PubMed ID: 16566941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O; Almazan G
    J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
    Geddis AE; Fox NE; Kaushansky K
    Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear stress and vascular smooth muscle cells promote endothelial differentiation of endothelial progenitor cells via activation of Akt.
    Ye C; Bai L; Yan ZQ; Wang YH; Jiang ZL
    Clin Biomech (Bristol, Avon); 2008; 23 Suppl 1():S118-24. PubMed ID: 17928113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
    Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
    Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals.
    Takizawa H; Eto K; Yoshikawa A; Nakauchi H; Takatsu K; Takaki S
    Exp Hematol; 2008 Jul; 36(7):897-906. PubMed ID: 18456388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic angiogenesis of human early endothelial progenitor cells is enhanced by thrombomodulin.
    Li JY; Su CH; Wu YJ; Tien TY; Hsieh CL; Chen CH; Tseng YM; Shi GY; Wu HL; Tsai CH; Lin FY; Yeh HI
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2518-25. PubMed ID: 21836068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas.
    Dobashi Y; Suzuki S; Matsubara H; Kimura M; Endo S; Ooi A
    Cancer; 2009 Jan; 115(1):107-18. PubMed ID: 19090006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins contribute to enhancement of the number and the function of endothelial progenitor cells from peripheral blood.
    Zhu JH; Tao QM; Chen JZ; Wang XX; Zhu JH; Shang YP
    Sheng Li Xue Bao; 2004 Jun; 56(3):357-64. PubMed ID: 15224150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.
    Llevadot J; Murasawa S; Kureishi Y; Uchida S; Masuda H; Kawamoto A; Walsh K; Isner JM; Asahara T
    J Clin Invest; 2001 Aug; 108(3):399-405. PubMed ID: 11489933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy.
    Foubert P; Matrone G; Souttou B; Leré-Déan C; Barateau V; Plouët J; Le Ricousse-Roussanne S; Lévy BI; Silvestre JS; Tobelem G
    Circ Res; 2008 Sep; 103(7):751-60. PubMed ID: 18723447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.